Clinical Trials
3 trialsNCT05241613 2025-02-13
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc
Phase 1 Terminated
NCT05673109 2024-01-25
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc
Phase 1 Terminated
NCT03478904 2021-05-10
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated